Skip to content
J

Jaqueline Meert Parlow

Publications (2)

The Impact of the 2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension on a Population Sample with a Mean Age of 59 Years

Mario Claudio Soares Sturzeneker, Karyn Maria Wenglarek, Jaqueline Meert Parlow, Bruna Karas, Gabriel dos Santos, Fabio de Castro Machado, Ana Beatriz Serrato Carmo, Lorena Grollmann, Laura Moscardi Milléo, Miguel Antonio Schuler Zoni, Alvaro Ivanski Sabedotti & Thiemy Vaz · Journal of Advances in Medicine and Medical Research · 2025

Introduction: Hypertension is a challenge for the global healthcare system due to its high prevalence and importance as a risk factor for the development of cardiovascular disease (CVD) and premature death. Its control remains unsatisfactory, despite the proven efficacy and good...

Open access Research Article 10.9734/jammr/2025/v37i105960

Angiotensin System Blockers in Experimental NAFLD/MASLD: Is there a Preferential Pathway or Drug?

Mario Claudio Soares Sturzeneker, Flávia Cristina Colmenero, Jaqueline Meert Parlow, Isabela Hess Justus, Crisangela Cristin Consul, Gabriel dos Santos, Maíza Pellissari Migliorini, Karyn Maria Wenglarek & Thais de Lima da Silva · Journal of Advances in Medicine and Medical Research · 2024

Introduction: Nonalcoholic fatty liver disease (NAFLD), currently known as metabolic dysfunction-associated steatotic liver disease (MASLD), is a persistent challenge in medical practice. Its global prevalence has progressively increased, with an estimated 30.1%. NAFLD has been a...

Open access Research Article 10.9734/jammr/2024/v36i115635